Research and Markets (http://www.researchandmarkets.com/research/8pcpr4/u_s_market_for)
has announced the addition of the "U.S.
Market for Cardiac Rhythm Managment, Electrophysiology and Ablation
(Executive Summary)" report to their offering.
In 2012, the U.S. market for cardiac rhythm management (CRM),
electrophysiology and ablation devices market was valued at nearly $6.8
The CRM, electrophysiology and ablation device market includes
pacemakers, cardia resynchronization therapy (CRT) devices, implantable
cardioverter defibrillators (ICDs), cardiac stimulation leads, external
defibrillators, ablation catheters, diagnostic electrophysiology (EP)
catheters, intracardiac ultrasound (ICE) catheters, electrophysiology
(EP) stimulators, diagnostic ECG and cardiac monitoring devices. Over
the forecast period, the CRM, electrophysiology and ablation device
market will be driven by the aging population, rise in cardiac ablation
procedures and adoption of advanced CRM devices. However, the aftermath
of the economic recession of 2008 and the sluggish U.S. economy that
followed have continued to stifle growth in the markets.
Scope: This report pertains to a forecast period of 10 years (2009 -
2019) for the U.S.
- Competitor Analysis
- Identified Strategic Opportunities
- Market Overview by Segment
- Trend Analysis by Segment
- Market Drivers & Limiters
- Mergers & Acquisitions
- Customer Feedback and Market Monitoring
For more information visit http://www.researchandmarkets.com/research/8pcpr4/u_s_market_for
[ Back To NFVZone's Homepage ]